Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis

By Revicki Dennis   Willian Mary Kaye   Menter Alan   Gordon Kenneth   Kimball Alexa   Leonardi Craig   Langley Richard   Kimel Miriam   Okun Martin  

Journal of Dermatological Treatment, Vol. 18, Iss. 6, 2007-01 ,pp. : 341-350

Informa Healthcare

Access to resources Recommend Favorite

Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I

By Pariser David   Gordon Kenneth   Papp Kim   Leonardi Craig   Kwon Paul   Compton Peter   Rundle Amy   Walicke Patricia   Lebwohl Mark  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 6, 2005-12 ,pp. : 303-312

Springer Publishing Company

Access to resources Recommend Favorite

The pharmacoeconomics of acne treatment: Where are we heading?

By Inglese Marc   Fleischer Alan   Feldman Steven   Balkrishnan Rajesh  

Journal of Dermatological Treatment, Vol. 19, Iss. 1, 2007-12 ,pp. : 27-37

Informa Healthcare

Access to resources Recommend Favorite

Exploring the impact of weight loss on the severity of psoriasis

By Tucker Rod  

Dermatological Nursing, Vol. 14, Iss. 3, 2015-09 ,pp. : 10-16

British Dermatological Nursing Group

Access to resources Recommend Favorite

Addition of a Topical Corticosteroid in the Early Phase of Alefacept Treatment for Psoriasis

By Bovenschen H. Jorn   Gerritsen Wil-Janne   de Jong Elke M.G. J.   van de Kerkhof Peter C. M.  

Acta Dermato-Venereologica, Vol. 86, Iss. 3, 2006-05 ,pp. : 281-282

Medical Journals Limited

Access to resources Recommend Favorite